QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the QIAprep&amp Plasmodium Kit and two companion assays to support malaria research and surveillance efforts.

Malaria parasites undergo an extensive metamorphosis after invasion of erythrocytes. This induces an increase in the surface ...

Malaria has been described as Nigeria’s most enduring public health challenge. Caused by parasites of the genus Plasmodium, ...

Nitisinone, a drug that is already used to treat two genetic diseases, could be repurposed to control the spread of malaria, ...

Malaria remains a major global health threat, with more than 250 million cases and 600,000 deaths in 2024 – over 90% of them in Africa QIAprep&amp Plasmodium Kit enables streamlined detection of ...

Malaria remains a major global health threat, with more than 250 million cases and 600,000 deaths in 2024 – over 90% of them ...

(RTTNews) - QIAGEN N.V. (QGEN) has unveiled the QIAprep& Plasmodium Kit along with two companion assays to enhance efforts in malaria research and monitoring. This innovative solution streamlines ...

Using focused ion beam milling and electron cryo-tomography, we studied dynamic actin filaments in unperturbed Plasmodium falciparum cells for the first time. This allowed us to dissect the assembly, ...